TRUE Earnings

TRUE reported its FY2025Q3 earnings on 2025-11-05, showcasing a revenue of 43.00M against an estimate of 48.00M, resulting in a -10.16% surprise. The EPS was -0.04, surpassing the expected -0.06 by 33.33% . The stock experienced a 0% price change on the earnings day and a 4.09% change over the next five days, reflecting market reactions to the results.

Following TRUE's FY2025Q3 earnings announcement on 2025-11-05, the stock price moved by 0.00% on the day of the release. Over the subsequent five days, it saw a 4.09% change. Historically, TRUE's stock price tends to shift by an average of +2.16% in the 10 days leading up to earnings and -4.15% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate TRUE’s annual revenue to reach 49.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between TRUE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TRUE's stock price typically moves by +2.16% in the 10 days before its earnings and -4.15% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 49.00M.

The earnings call presents mixed signals. Financial performance shows some positive trends, such as revenue and unit sales growth, but lacks guidance and has negative EBITDA. Product development and market strategy are promising with new initiatives and partnerships, yet concerns about tariffs and vague management responses in the Q&A weigh negatively. The lack of guidance and cautious capital allocation suggest uncertainty. Despite positive shareholder return potential, the overall sentiment is neutral due to mixed financial health and unclear future outlook.